166 related articles for article (PubMed ID: 7665251)
1. Neoplastic progression of human colorectal cancer is associated with overexpression of the stromelysin-3 and BM-40/SPARC genes.
Porte H; Chastre E; Prevot S; Nordlinger B; Empereur S; Basset P; Chambon P; Gespach C
Int J Cancer; 1995 Feb; 64(1):70-5. PubMed ID: 7665251
[TBL] [Abstract][Full Text] [Related]
2. Overexpression of stromelysin-3, BM-40/SPARC, and MET genes in human esophageal carcinoma: implications for prognosis.
Porte H; Triboulet JP; Kotelevets L; Carrat F; Prévot S; Nordlinger B; DiGioia Y; Wurtz A; Comoglio P; Gespach C; Chastre E
Clin Cancer Res; 1998 Jun; 4(6):1375-82. PubMed ID: 9626453
[TBL] [Abstract][Full Text] [Related]
3. Stromelysin 3 belongs to a subgroup of proteinases expressed in breast carcinoma fibroblastic cells and possibly implicated in tumor progression.
Wolf C; Rouyer N; Lutz Y; Adida C; Loriot M; Bellocq JP; Chambon P; Basset P
Proc Natl Acad Sci U S A; 1993 Mar; 90(5):1843-7. PubMed ID: 8446598
[TBL] [Abstract][Full Text] [Related]
4. Increased stromelysin 3 gene expression is associated with increased local invasiveness in head and neck squamous cell carcinomas.
Muller D; Wolf C; Abecassis J; Millon R; Engelmann A; Bronner G; Rouyer N; Rio MC; Eber M; Methlin G
Cancer Res; 1993 Jan; 53(1):165-9. PubMed ID: 7677979
[TBL] [Abstract][Full Text] [Related]
5. Expression and localization of matrix-degrading metalloproteinases during colorectal tumorigenesis.
Newell KJ; Witty JP; Rodgers WH; Matrisian LM
Mol Carcinog; 1994 Aug; 10(4):199-206. PubMed ID: 8068180
[TBL] [Abstract][Full Text] [Related]
6. Stromelysin-3 (ST-3) mRNA expression in colorectal carcinomas. Localization and clinicopathologic correlations.
Thewes M; Pohlmann G; Atkinson M; Mueller J; Pütz B; Höfler H
Diagn Mol Pathol; 1996 Dec; 5(4):284-90. PubMed ID: 8955621
[TBL] [Abstract][Full Text] [Related]
7. Modulation of human stromelysin 3 promoter activity and gene expression by human breast cancer cells.
Ahmad A; Marshall JF; Basset P; Anglard P; Hart IR
Int J Cancer; 1997 Oct; 73(2):290-6. PubMed ID: 9335457
[TBL] [Abstract][Full Text] [Related]
8. Expression and in-situ localization of genes coding for extracellular matrix proteins and extracellular matrix degrading proteases in pancreatic cancer.
Gress TM; Müller-Pillasch F; Lerch MM; Friess H; Büchler M; Adler G
Int J Cancer; 1995 Aug; 62(4):407-13. PubMed ID: 7635566
[TBL] [Abstract][Full Text] [Related]
9. Elevated tissue inhibitor of metalloproteinase 1 RNA in colorectal cancer stroma correlates with lymph node and distant metastases.
Zeng ZS; Cohen AM; Zhang ZF; Stetler-Stevenson W; Guillem JG
Clin Cancer Res; 1995 Aug; 1(8):899-906. PubMed ID: 9816060
[TBL] [Abstract][Full Text] [Related]
10. Clinicopathological significance of stromelysin-3 expression in colorectal cancer.
Skoglund J; Emterling A; Arbman G; Anglard P; Sun XF
Oncology; 2004; 67(1):67-72. PubMed ID: 15459498
[TBL] [Abstract][Full Text] [Related]
11. Stromelysin-3 in stromal tissue as a control factor in breast cancer behavior.
Basset P; Wolf C; Rouyer N; Bellocq JP; Rio MC; Chambon P
Cancer; 1994 Aug; 74(3 Suppl):1045-9. PubMed ID: 7518738
[TBL] [Abstract][Full Text] [Related]
12. Lymphovascular invasion of colorectal cancer is correlated to SPARC expression in the tumor stromal microenvironment.
Yoshimura T; Nagahara M; Kuo C; Turner RR; Soon-Shiong P; Hoon DS
Epigenetics; 2011 Aug; 6(8):1001-11. PubMed ID: 21725199
[TBL] [Abstract][Full Text] [Related]
13. Relationship between the expression of the extracellular matrix genes SPARC, SPP1, FN1, ITGA5 and ITGAV and clinicopathological parameters of tumor progression and colorectal cancer dissemination.
Viana Lde S; Affonso RJ; Silva SR; Denadai MV; Matos D; Salinas de Souza C; Waisberg J
Oncology; 2013; 84(2):81-91. PubMed ID: 23128103
[TBL] [Abstract][Full Text] [Related]
14. Expression and localization of the matrix metalloproteinase pump-1 (MMP-7) in human gastric and colon carcinomas.
McDonnell S; Navre M; Coffey RJ; Matrisian LM
Mol Carcinog; 1991; 4(6):527-33. PubMed ID: 1793490
[TBL] [Abstract][Full Text] [Related]
15. Stromelysin-3 gene expression in human cancer: an overview.
Rouyer N; Wolf C; Chenard MP; Rio MC; Chambon P; Bellocq JP; Basset P
Invasion Metastasis; 1994-1995; 14(1-6):269-75. PubMed ID: 7657519
[TBL] [Abstract][Full Text] [Related]
16. Distribution of stromelysin-3 mRNA transcripts and microvessels in human breast carcinomas.
Linder C; Engel G; Auer G; Strander H; Linder S
Breast Cancer Res Treat; 1997 Feb; 42(3):207-13. PubMed ID: 9065604
[TBL] [Abstract][Full Text] [Related]
17. Correlation between stromelysin-3 mRNA level and outcome of human breast cancer.
Engel G; Heselmeyer K; Auer G; Bäckdahl M; Eriksson E; Linder S
Int J Cancer; 1994 Sep; 58(6):830-5. PubMed ID: 7927875
[TBL] [Abstract][Full Text] [Related]
18. Expression of stromelysin-3 and nm23 in breast carcinoma and related tissues.
Hähnel E; Dawkins H; Robbins P; Hähnel R
Int J Cancer; 1994 Jul; 58(2):157-60. PubMed ID: 8026874
[TBL] [Abstract][Full Text] [Related]
19. Expression pattern of metalloproteinases and their inhibitors changes with the progression of human sporadic colorectal neoplasia.
Urbanski SJ; Edwards DR; Hershfield N; Huchcroft SA; Shaffer E; Sutherland L; Kossakowska AE
Diagn Mol Pathol; 1993 Jun; 2(2):81-9. PubMed ID: 8269281
[TBL] [Abstract][Full Text] [Related]
20. Expression of urokinase-type plasminogen activator, stromelysin 1, stromelysin 3, and matrilysin genes in lung carcinomas.
Bolon I; Devouassoux M; Robert C; Moro D; Brambilla C; Brambilla E
Am J Pathol; 1997 May; 150(5):1619-29. PubMed ID: 9137088
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
